Ondansetron ODT 8 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM3MX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,548
Award facts
- Contract value 100% obligated
- $14,548.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 29, 2026, for the supply of Ondansetron ODT 8 mg tablets (30-count) with a ceiling value of $14,548.02. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and was funded by the Defense Logistics Agency (DLA), a defense agency. No set-aside designation was applied to this award, indicating it was competitively awarded on a full and open basis. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), which serves as the parent organization in the federal pharmaceutical supply chain.
This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract supports critical federal healthcare programs serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM3MX?
SPE2DR26FM3MX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FM3MX worth?
The government has obligated $14,548 on SPE2DR26FM3MX.
Is contract SPE2DR26FM3MX an order under another contract?
Yes. SPE2DR26FM3MX is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM3MX competed?
The extent of competition for SPE2DR26FM3MX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award